Poly Medicure Limited (POLYMED) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Poly Medicure Limited (POLYMED) has a cash flow conversion efficiency ratio of 0.031x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs914.43 Million ≈ $9.89 Million USD) by net assets (Rs29.32 Billion ≈ $317.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Poly Medicure Limited - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Poly Medicure Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Poly Medicure Limited (POLYMED) total liabilities for a breakdown of total debt and financial obligations.
Poly Medicure Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Poly Medicure Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Veritex Holdings Inc
NASDAQ:VBTX
|
0.017x |
|
Sparebank 1 Nord-Norge
OL:NONG
|
0.132x |
|
Playa Hotels & Resorts BV
NASDAQ:PLYA
|
0.147x |
|
Ningbo Ocean Shipping Co. Ltd. A
SHG:601022
|
N/A |
|
SLC Agrícola S.A
SA:SLCE3
|
0.152x |
|
Sobha Limited
NSE:SOBHA
|
0.063x |
|
S&T Bancorp Inc
NASDAQ:STBA
|
0.028x |
|
PT Arkora Hydro Tbk
JK:ARKO
|
-0.153x |
Annual Cash Flow Conversion Efficiency for Poly Medicure Limited (2006–2025)
The table below shows the annual cash flow conversion efficiency of Poly Medicure Limited from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Poly Medicure Limited worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs27.66 Billion ≈ $299.10 Million |
Rs2.40 Billion ≈ $26.00 Million |
0.087x | -51.97% |
| 2024-03-31 | Rs14.70 Billion ≈ $158.98 Million |
Rs2.66 Billion ≈ $28.78 Million |
0.181x | +17.77% |
| 2023-03-31 | Rs12.42 Billion ≈ $134.28 Million |
Rs1.91 Billion ≈ $20.64 Million |
0.154x | +35.36% |
| 2022-03-31 | Rs10.87 Billion ≈ $117.61 Million |
Rs1.23 Billion ≈ $13.35 Million |
0.114x | -7.67% |
| 2021-03-31 | Rs9.66 Billion ≈ $104.42 Million |
Rs1.19 Billion ≈ $12.84 Million |
0.123x | -59.03% |
| 2020-03-31 | Rs4.35 Billion ≈ $47.02 Million |
Rs1.31 Billion ≈ $14.11 Million |
0.300x | +6.85% |
| 2019-03-31 | Rs3.81 Billion ≈ $41.24 Million |
Rs1.07 Billion ≈ $11.58 Million |
0.281x | +26.82% |
| 2018-03-31 | Rs3.38 Billion ≈ $36.59 Million |
Rs749.28 Million ≈ $8.10 Million |
0.221x | +4.36% |
| 2017-03-31 | Rs2.64 Billion ≈ $28.59 Million |
Rs561.17 Million ≈ $6.07 Million |
0.212x | -23.46% |
| 2016-03-31 | Rs2.29 Billion ≈ $24.73 Million |
Rs633.95 Million ≈ $6.86 Million |
0.277x | -14.07% |
| 2015-03-31 | Rs1.96 Billion ≈ $21.22 Million |
Rs633.05 Million ≈ $6.85 Million |
0.323x | -27.89% |
| 2014-03-31 | Rs1.46 Billion ≈ $15.84 Million |
Rs655.39 Million ≈ $7.09 Million |
0.447x | +29.58% |
| 2013-03-31 | Rs1.12 Billion ≈ $12.16 Million |
Rs388.35 Million ≈ $4.20 Million |
0.345x | -2.14% |
| 2012-03-31 | Rs935.63 Million ≈ $10.12 Million |
Rs330.19 Million ≈ $3.57 Million |
0.353x | +17.52% |
| 2011-03-31 | Rs781.74 Million ≈ $8.45 Million |
Rs234.75 Million ≈ $2.54 Million |
0.300x | -14.34% |
| 2010-03-31 | Rs606.36 Million ≈ $6.56 Million |
Rs212.56 Million ≈ $2.30 Million |
0.351x | +23.52% |
| 2009-03-31 | Rs479.72 Million ≈ $5.19 Million |
Rs136.15 Million ≈ $1.47 Million |
0.284x | +20.42% |
| 2008-03-31 | Rs420.98 Million ≈ $4.55 Million |
Rs99.21 Million ≈ $1.07 Million |
0.236x | -26.52% |
| 2007-03-31 | Rs349.99 Million ≈ $3.79 Million |
Rs112.25 Million ≈ $1.21 Million |
0.321x | -21.19% |
| 2006-03-31 | Rs278.57 Million ≈ $3.01 Million |
Rs113.36 Million ≈ $1.23 Million |
0.407x | -- |
About Poly Medicure Limited
Poly Medicure Limited engages in the manufacture and sale of medical devices in India and internationally. The company offers infusion therapy products, such as I.V Infusion set, extension lines, needle free connector, I.V flow regulator extension set, burette set, three way stop cock, vial access spike, transfer spike, orburator, polyflush, maifolds, polyswab, and arterial blood collection; crit… Read more